Autoimmune lymphoproliferative syndrome surgery

Autoimmune lymphoproliferative syndrome Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Autoimmune lymphoproliferative syndrome surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune lymphoproliferative syndrome surgery
CDC on Autoimmune lymphoproliferative syndrome surgery
Autoimmune lymphoproliferative syndrome surgery in the news
Blogs on Autoimmune lymphoproliferative syndrome surgery
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sharmi Biswas, M.B.B.S

Overview

No definitive surgery is required to treat Autoimmune lymphoproliferative syndrome(ALPS).

Surgery

Splenectomy is the only surgery used to treat ALPS. But splenectomy is reserved as the last treatment option in patients with severe refractory cytopenias, severe hypersplenism to avoid the high risk of recurrence cytopenias and sepsis in post-splenectomy patients with ALPS.